Document Classification

Section Type: RESULTS

Text: There was no statistically significant difference between IVL745 and placebo in the effect on the LAR after allergen challenge, as measured by the area under the curve of the percentage change in FEV1 from the prechallenge baseline (mean [SEM], -81. 99 [18. 80] after IVL745 and -72. 58 [21. 29] after placebo ; 95 % CI of difference, -36 to 16. 8 ; P =. 46) or by the maximum percentage change from the prechallenge baseline (mean [SEM], -23. 44 [4. 73] after IVL745 and -21. 30 [5. 17] after placebo ; 95 % CI of difference, -11 to 6. 29 ; P =. 60).